Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-02-24Clinical Trial Update: Locally Advanced NSCLC Hyperfractionated RT [Phase 2]
Phase 2 trial update on locally advanced non-small cell lung cancer using hyperfractionated radiotherapy; study completed with results poste…
-
CLINICAL_TRIALS trial_result · 2020-02-24Clinical Trial Update: Phase I Trial Of IMRT Using A Contralateral Esophagus Sparing Technique (CEST) In Locally Advanced Lung Cancer [NA]
Phase I trial evaluating a contralateral esophagus sparing technique (CEST) for IMRT in locally advanced lung cancer has completed with resu…
-
CLINICAL_TRIALS trial_result · 2020-02-21Clinical Trial Update: A Phase II Study to Evaluate the Efficacy and Safety of Oral Ceritinib in Patients With ALK-positive NSCLC Metastatic to the Brain and/or to Leptomeninges [Phase 2]
Phase II study evaluating oral ceritinib in ALK-positive non-small cell lung cancer with brain/leptomeningeal involvement; trial completed w…
-
CLINICAL_TRIALS trial_result · 2020-02-21Clinical Trial Update: Thoracic Re-irradiation For Locoregionally Recurrent Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial investigating thoracic re-irradiation for locoregionally recurrent non-small cell lung cancer after prior thoracic ra…
-
CLINICAL_TRIALS trial_result · 2020-02-18Clinical Trial Update: Neoadjuvant Pembrolizumab [Phase 2]
Phase 2 neoadjuvant trial of pembrolizumab in non-small cell lung cancer has completed. Results were posted on 2020-02-18.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-02-18Clinical Trial Update: Gefitinib Versus Vinorelbine/Platinum as Adjuvant Treatment in Stage II-IIIA(N1-N2) NSCLC With EGFR Mutation [Phase 3]
A Phase 3 trial comparing gefitinib to vinorelbine/platinum as adjuvant therapy in Stage II-IIIA(N1-N2) non-small cell lung cancer with EGFR…
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: Apatinib Combined With Vinorelbine for Non-driver Gene Mutation Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating apatinib in combination with vinorelbine for advanced non-small cell lung cancer with non-driver gene mutations has…
-
CLINICAL_TRIALS trial_result · 2020-02-13Clinical Trial Update: Docetaxel in Treating Older Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 2]
A phase 2 trial update examining docetaxel in older patients with locally advanced or metastatic non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2020-02-13Clinical Trial Update: A Clinical Trial of Fruquintinib in Patients With Advanced Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial of Fruquintinib in patients with advanced non-small cell lung cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2020-02-12Clinical Trial Update: A Two-arm (Phase 2) Exploratory Study of Nivolumab Monotherapy or in Combination With Nab-paclitaxel and Carboplatin in Early Stage NSCLC in China [Phase 2]
A Phase 2 two-arm exploratory trial evaluating nivolumab alone or combined with nab-paclitaxel and carboplatin in early-stage non-small cell…
-
CLINICAL_TRIALS trial_result · 2020-02-12Clinical Trial Update: Pemetrexed vs Pemetrexed Plus Cisplatin in EGFR-mutant NSCLC Patients After First Line EGFR-TKIs Failure [Phase 2]
Phase 2 trial comparing pemetrexed alone versus pemetrexed plus cisplatin in EGFR-mutant non-small cell lung cancer after failure of first-l…
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: A Study of the Efficacy and Safety of Alectinib in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of alectinib in ALK-rearranged non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: A Study for Reducing Symptom Burden Produced by Chemoradiation Treatment for Non Small Cell Lung Cancer by Minocycline and Armodafinil [NA]
A completed clinical trial investigating minocycline and armodafinil to reduce symptom burden from chemoradiation in non-small cell lung can…
-
FDA approval · 2020-02-08FDA Approved: PEMFEXY — Original Application (Eagle Pharmaceuticals, Inc.)
FDA approved PEMFEXY (pemetrexed) from Eagle Pharmaceuticals in an Original Application, adding a pemetrexed injection option.
-
CLINICAL_TRIALS trial_result · 2020-02-07Clinical Trial Update: Rh-endostatin Combined With Chemotherapy and Pembrolizumab for Advanced NSCLC [Phase 2]
Phase 2 trial examining rh-endostatin in combination with chemotherapy and pembrolizumab for advanced stage IV non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2020-02-07Clinical Trial Update: A Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) With Pembrolizumab in Participants With Selected Hyaluronan High Solid Tumors [Phase 1]
Phase 1 trial evaluating PEGPH20 with pembrolizumab in hyaluronan-high tumors including non-small cell lung cancer and gastric cancer; study…
-
CLINICAL_TRIALS trial_result · 2020-02-06Clinical Trial Update: Third-line Treatment of Gefitinib in NSCLC Patients [Phase 2]
A Phase 2 clinical trial update evaluating third-line gefitinib in non-small cell lung cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Pembrolizumab Plus Epacadostat vs Pembrolizumab Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-654-05/ECHO-305-05) [Phase 2]
Phase 2 trial KEYNOTE-654-05/ECHO-305-05 comparing pembrolizumab plus epacadostat versus pembrolizumab plus placebo in metastatic non-small …
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Hypofraction Radiotherapy in Patients With NSCLC [Phase 2]
Phase 2 trial of SHR-1210 (an anti-PD-1) combined with hypofractionated radiotherapy in non-small cell lung cancer (NSCLC).
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Durvalumab Combined With Chemotherapy and Stereotactic Body Radiotherapy (SBRT) in Patients With Oligometastatic Non-small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 clinical trial evaluating durvalumab with chemotherapy and SBRT for oligometastatic non-small cell lung cancer. The status is curren…
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Sintilimab Versus Pembrolizumab for Advanced-stage Non-Small-Cell Lung Cancer [Phase 2]
Phase 2 trial comparing sintilimab to pembrolizumab for advanced non-small cell lung cancer is ongoing with unpublished status.
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer [Phase 2]
Phase 2 study of Viagenpumatucel-L (HS-110) in non-small cell lung cancer was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-31Clinical Trial Update: A Study of NIVO Plus IPI and Guadecitabine or NIVO Plus IPI in Melanoma and NSCLC Resistant to Anti-PD1/PDL1 [Phase 2]
Phase 2 trial evaluating nivolumab plus ipilimumab with guadecitabine versus nivolumab plus ipilimumab in melanoma and non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2020-01-31Clinical Trial Update: LungTech: Stereotactic Body Radiotherapy (SBRT) of Inoperable Centrally Located NSCLC [Phase 2]
Phase 2 clinical trial update evaluating SBRT for inoperable centrally located non-small cell lung cancer (Stage I-II).
-
CLINICAL_TRIALS trial_result · 2020-01-29Clinical Trial Update: A Study of Pembrolizumab Plus Epacadostat With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-715-06/ECHO-306-06) [Phase 2]
Phase 2 trial evaluating pembrolizumab plus epacadostat with platinum-based chemotherapy versus pembrolizumab with platinum chemotherapy plu…